화상 치료 시장 : 제품 유형, 치료법, 화상 정도, 최종 사용자, 유통 채널별 - 세계 시장 예측(2026-2032년)

The Burn Care Market is projected to grow by USD 5.53 billion at a CAGR of 7.29% by 2032.

Burn Care Market Executive Summary

Burn care is advancing from episodic emergency treatment to an integrated continuum spanning prevention, triage, resuscitation, excision, grafting, infection control, rehabilitation, scar management, and long-term psychosocial recovery. This shift is increasing the importance of coordinated burn care pathways that connect emergency departments, intensive care units, operating rooms, outpatient wound clinics, rehabilitation teams, and community follow-up.

The clinical need remains substantial. The World Health Organization estimates that burns cause about 180,000 deaths annually, with the highest burden in low- and middle-income countries. Demand for advanced burn dressings, skin substitutes, biologics, antimicrobial solutions, teleburn services, and specialized burn centers is rising as health systems prioritize faster wound closure, lower infection risk, reduced length of stay, reduced scarring, pain control, and improved functional outcomes.

Transformative Shifts in Burn Care

The burn care landscape is being reshaped by early excision protocols, advanced wound care products, regenerative medicine, negative pressure wound therapy, antimicrobial stewardship, fluid resuscitation optimization, and multidisciplinary rehabilitation. Providers are increasingly measuring success through graft take, time to epithelialization, infection prevention, pain control, mobility restoration, scar reduction, psychological recovery, and quality of life.

Purchasers are also shifting toward value-based evidence. Hospitals, trauma networks, and payers are seeking burn care products that demonstrate reduced dressing changes, fewer complications, lower infection risk, shorter inpatient stays, and improved resource utilization. This creates opportunities for organizations with strong clinical evidence, scalable manufacturing, training support, regulatory readiness, and health economic data that can support adoption across acute and post-acute burn care settings.

Cumulative Impact of Artificial Intelligence in Burn Care

Artificial intelligence is creating cumulative impact across burn care by improving image-based burn depth assessment, supporting triage decisions, predicting sepsis and deterioration risk, optimizing operating room scheduling, standardizing wound documentation, and enabling remote follow-up. AI-enabled tools are especially relevant where burn specialists are scarce and rapid referral decisions affect survival, grafting needs, and long-term functional outcomes.

The greatest near-term value will come from human-in-the-loop applications that combine computer vision, electronic health record data, thermal imaging, clinical photographs, and standardized wound scoring. Industry leaders must address validation, bias, cybersecurity, regulatory compliance, interoperability, medicolegal accountability, and clinical workflow integration before AI can move from pilot programs to routine burn care delivery.

Key Regional Burn Care Insights

Asia-Pacific carries a large burn burden due to population scale, household cooking exposures, industrialization, electrical injuries, and uneven access to specialized centers, with countries investing in tertiary care, emergency response, and telemedicine to improve referral and follow-up. North America benefits from established burn networks, emergency medical services, rehabilitation capacity, burn registries, and strong adoption of advanced dressings, skin substitutes, and infection control protocols. Latin America shows rising demand for cost-effective antimicrobial wound care, surgical capacity, critical care infrastructure, and rehabilitation services as urban trauma systems and public hospital networks develop.

Europe is characterized by mature reimbursement pathways, clinical guidelines, national burn services, and strong research collaboration across specialized burn units, with emphasis on outcomes, scar management, and quality of life. The Middle East is investing in trauma, emergency care, and critical care infrastructure through national health modernization programs, supporting adoption of advanced burn care technologies and digital health systems. Africa faces the most significant access gap, where burn prevention, rapid referral, affordable dressings, infection control, surgical workforce training, and rehabilitation access remain essential to reducing mortality and disability.

Key Group Insights Across Burn Care Markets

ASEAN burn care needs are shaped by household burn prevention, industrial safety, hospital infrastructure expansion, and demand for affordable wound care products that can be used in resource-variable settings. The GCC is prioritizing specialized trauma care, premium hospital capacity, emergency preparedness, and digital health integration, supporting adoption of advanced burn care technologies, telemedicine, and multidisciplinary rehabilitation. The European Union emphasizes harmonized regulation, evidence generation, post-market surveillance, cross-border clinical research, and standardized quality measures across burn centers.

BRICS countries combine high patient volumes with expanding domestic manufacturing, public hospital procurement, tertiary care investment, and growing demand for cost-effective advanced dressings, skin substitutes, and infection control solutions. G7 health systems remain important for burn care innovation, reimbursement evidence, specialist care standards, registry-based outcomes, and adoption of regenerative therapies. NATO-aligned health systems also strengthen burn readiness through disaster medicine, military trauma care, chemical and thermal injury preparedness, and mass-casualty response planning.

Key Country Insights for Burn Care

The United States leads in specialized burn centers, clinical research, registry-based quality improvement, and advanced product adoption, while Canada emphasizes regionalized trauma systems, transfer coordination, telehealth, and equitable access across large geographies. Mexico and Brazil show growing need for hospital-based burn capacity, affordable advanced dressings, infection prevention, critical care resources, and rehabilitation access. The United Kingdom, Germany, France, Italy, and Spain benefit from established public health systems, surgical expertise, multidisciplinary rehabilitation pathways, and guideline-driven burn care, while Russia's demand is linked to trauma infrastructure, industrial injury management, cold-climate household risks, and broad geographic coverage.

China and India represent high-volume burn care environments with increasing investment in tertiary hospitals, emergency care, domestic manufacturing, digital health, and telemedicine-supported access beyond major cities. Japan, Australia, and South Korea are advanced markets focused on aging populations, precision wound assessment, infection control, regenerative therapies, scar management, rehabilitation, and quality-of-life outcomes after burn injury, with Australia also emphasizing regional access and long-distance specialist referral.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically differentiated burn care products that reduce infection risk, accelerate wound closure, support graft take, minimize pain, and simplify care delivery across emergency departments, operating rooms, intensive care units, burn units, rehabilitation services, and outpatient settings. Evidence packages should include randomized or real-world data, health economic outcomes, usability findings, training requirements, and workflow benefits for clinicians and health systems.

Organizations should also expand clinical education, partner with burn centers, support prevention and referral programs, localize products for cost-sensitive markets, and integrate digital documentation or teleburn support. Long-term advantage will come from combining advanced materials, regenerative platforms, antimicrobial strategies, data-enabled wound monitoring, and AI-assisted clinical decision support while maintaining affordability, regulatory compliance, and equitable access.

Research Methodology

This executive summary is developed through secondary research from public health agencies, burn associations, peer-reviewed clinical literature, regulatory sources, hospital practice guidelines, trauma system publications, and publicly available industry disclosures. Key inputs include WHO burn epidemiology, national burn registry publications, wound care standards, surgical burn management guidelines, infection prevention recommendations, and rehabilitation literature.

Insights are synthesized using market segmentation, regional demand mapping, technology adoption analysis, reimbursement review, regulatory assessment, clinical evidence review, and competitive benchmarking without presenting market sizing, market share, or forecasting. Emphasis is placed on verifiable clinical trends, evidence-backed care pathways, unmet needs, and practical implications for manufacturers, providers, investors, policymakers, and health system leaders.

Conclusion

Burn care is entering a new phase defined by faster diagnosis, evidence-based wound closure, regenerative technologies, infection control, digital follow-up, AI-enabled decision support, rehabilitation integration, and outcomes-driven purchasing. The burden of burn injuries remains global, but needs differ sharply by region, income level, infrastructure, specialist availability, emergency response capacity, and rehabilitation access.

Organizations that align innovation with clinical evidence, affordability, workforce training, regulatory readiness, and regional access will be best positioned to lead. Sustainable progress in burn care will depend on improving survival, reducing infection and disability, shortening recovery, restoring patient function, and supporting physical and psychosocial recovery across the entire burn care continuum.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Burn Care Market, by Product Type

• 7.1. Devices
  • 7.1.1. Laser Therapy Devices
  • 7.1.2. Wound Vacuum Assisted Closure
• 7.2. Dressings
  • 7.2.1. Alginate
  • 7.2.2. Film
  • 7.2.3. Foam
  • 7.2.4. Hydrocolloid
  • 7.2.5. Hydrogel
• 7.3. Grafts And Bioengineered Skin Substitutes
  • 7.3.1. Allografts
  • 7.3.2. Autografts
  • 7.3.3. Synthetic Skin Substitutes
  • 7.3.4. Xenografts

8. Burn Care Market, by Treatment Type

• 8.1. Non-Surgical
  • 8.1.1. Dressing Application
  • 8.1.2. Pharmacotherapy
• 8.2. Surgical
  • 8.2.1. Debridement
  • 8.2.2. Skin Grafting

9. Burn Care Market, by Burn Degree

• 9.1. First Degree
• 9.2. Second Degree
• 9.3. Third Degree

10. Burn Care Market, by End User

• 10.1. Ambulatory Surgical Centers
• 10.2. Burn Care Clinics
• 10.3. Homecare Settings
• 10.4. Hospitals

11. Burn Care Market, by Distribution Channel

• 11.1. Hospital Pharmacies
• 11.2. Retail Pharmacies
  • 11.2.1. Chain Pharmacies
  • 11.2.2. Independent Pharmacies

12. Burn Care Market, by Region

• 12.1. Asia-Pacific
• 12.2. North America
• 12.3. Latin America
• 12.4. Europe
• 12.5. Middle East
• 12.6. Africa

13. Burn Care Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Burn Care Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. Competitive Landscape

• 15.1. Market Concentration Analysis, 2025
  • 15.1.1. Concentration Ratio (CR)
  • 15.1.2. Herfindahl Hirschman Index (HHI)
• 15.2. Recent Developments & Impact Analysis, 2025
• 15.3. Product Portfolio Analysis, 2025
• 15.4. Benchmarking Analysis, 2025

16. Company Profiles

• 16.1. 3M Company
• 16.2. Advanced Medical Solutions Group PLC
• 16.3. Airgas, Inc.
• 16.4. Anika Therapeutics, Inc.
• 16.5. B. Braun SE
• 16.6. Boiron, Inc.
• 16.7. Cardinal Health, Inc.
• 16.8. Cipla Limited
• 16.9. Coloplast A/S
• 16.10. ConvaTec Group PLC
• 16.11. DeRoyal Industries, Inc.
• 16.12. FIBROHEAL WOUNDCARE PVT. LTD
• 16.13. Hollister Incorporated
• 16.14. Integra LifeSciences Corporation
• 16.15. Johnson & Johnson Services, Inc.
• 16.16. M/s Dr. Sabharwal's Mfg. Labs Ltd.
• 16.17. Medline Industries, Inc.
• 16.18. Molnlycke Health Care AB
• 16.19. Orkla Group.
• 16.20. Paul Hartmann AG
• 16.21. Pfizer Inc.
• 16.22. Safe N Simple LLC.
• 16.23. Smith & Nephew PLC
• 16.24. Triage Meditech Pvt. Ltd.